Sunshine Biopharma expands board to 5, adds 3 independent directors, aims for Nasdaq uplist

Sunshine Biopharma Inc.

Board expanded from 3 to 5 members; added Andrew Telsey (legal), JD Kish (accounting), Dr. Rabi Kiderchah (medical).
Camille Sebaaly resigned as director but remains CFO.
New appointments part of Company's application process to uplist to Nasdaq.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

JD Kish

Director

SBFM · Sunshine Biopharma Inc.

Effective: 2021-10-31
Filed: November 3, 2021, 7:59 PM ET

The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors

Appointed

Rabi Kiderchah

Director

SBFM · Sunshine Biopharma Inc.

Effective: 2021-10-31
Filed: November 3, 2021, 7:59 PM ET

The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors

Appointed

Andrew Telsey

Director

SBFM · Sunshine Biopharma Inc.

Effective: 2021-10-31
Filed: November 3, 2021, 7:59 PM ET

The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

JD Kish was appointed as Director at Sunshine Biopharma Inc..

Action: added
Role: Director

Exact text from the filing

The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Rabi Kiderchah was appointed as Director at Sunshine Biopharma Inc..

Action: added
Role: Director

Exact text from the filing

The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Telsey was appointed as Director at Sunshine Biopharma Inc..

Action: added
Role: Director

Exact text from the filing

The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors

View on SEC.gov

Sunshine Biopharma Inc. filing history →

Source: SEC EDGAR

accession 0001683168-21-005210

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.